Navigating complex choices through legitimation: Narrative strategies in risk-reduction mastectomy decision-making among unaffected women with genetic risk for breast cancer in Switzerland

For unaffected women at high risk for developing breast cancer due to pathogenic variants in BRCA1 or BRCA2 (BRCA) genes, bilateral risk-reducing mastectomy (RRM) is an alternative to intensive surveillance. RRM reduces breast cancer risk but may generate additional health and psychosocial issues, making the choice between surveillance and RRM complex and personal. This grounded theory study explores how unaffected women carrying BRCA pathogenic variants engage in a decision-making process leading to the choice of undergoing RRM. Narrative data were collected in Switzerland through biographical interviews with 38 unaffected women carrying BRCA pathogenic variants. Participants had either undergone RRM or were planning the surgery in the future. Findings indicate that the decision to undergo RRM was influenced by femininity and body image, current life engagements, anticipation of surgery risks and outcomes, perception and acceptance of cancer risk, surveillance experiences, attitudes of healthcare providers and family, and financial considerations. These factors interacted, creating contradictions that made decision-making challenging. To navigate this uncertainty, women progressively built their decision through a triple process of making sense: framing RRM as an obligated, empowering and mundane choice. This sense-making process is described as a process of legitimation, through which women decide to undergo RRM and integrate it into their life trajectory, ensuring its acceptability for themselves and their social circles. The discussion provides insights into the legitimation process as a heuristic tool for exploring crucial choices in uncertainty and offers implications for healthcare providers assisting individuals in complex decision-making processes. • RRM decision-making is a challenging process marked by a complex nexus of drivers. • Women gradually build RRM decisions within their family and care providers. • Building a RRM decision requires making sense through a process of legitimation. • RRM decision-making entails framing as an obligated, empowering and mundane choice. • Women need comprehensive support to construct their RRM decision.

Authors

Institutions

Publication Details

Journal
SSM - Qualitative Research in Health
Published
2024-12-30
DOI
https://doi.org/10.1016/j.ssmqr.2024.100522
Citations
1
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.55

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Navigating complex choices through legitimation: Narrative strategies in risk-reduction mastectomy decision-making among unaffected women with genetic risk for breast cancer in Switzerland

Ursina Zürrer‐Härdi, Mónica Aceti, Rossella Graffeo, Eckhard Schönaü et al.
1 citations
SSM - Qualitative Research in Health
BRCA gene mutations in cancer
0.55
article

Navigating complex choices through legitimation: Narrative strategies in risk-reduction mastectomy decision-making among unaffected women with genetic risk for breast cancer in Switzerland

Ursina Zürrer‐Härdi, Mónica Aceti, Rossella Graffeo, Eckhard Schönaü, Carla Pedrazzani, Simon Wieser, Karl Heinimann, Souria Aissaoui, Reka Schweighoffer, Maria Caiata Zufferey, Pierre O. Chappuis, Maria C. Katapodi, Fulvia Brugnoletti, Murat Aykut, Manuela Rabaglio, Olivia Pagani, Christian Monnerat, Nicole Bürki, Muriel Fluri, Rachel Bunger, Ashley Machen, Mekdes Alemu
article en
1 citations

Abstract

For unaffected women at high risk for developing breast cancer due to pathogenic variants in BRCA1 or BRCA2 (BRCA) genes, bilateral risk-reducing mastectomy (RRM) is an alternative to intensive surveillance. RRM reduces breast cancer risk but may generate additional health and psychosocial issues, making the choice between surveillance and RRM complex and personal. This grounded theory study explores how unaffected women carrying BRCA pathogenic variants engage in a decision-making process leading to the choice of undergoing RRM. Narrative data were collected in Switzerland through biographical interviews with 38 unaffected women carrying BRCA pathogenic variants. Participants had either undergone RRM or were planning the surgery in the future. Findings indicate that the decision to undergo RRM was influenced by femininity and body image, current life engagements, anticipation of surgery risks and outcomes, perception and acceptance of cancer risk, surveillance experiences, attitudes of healthcare providers and family, and financial considerations. These factors interacted, creating contradictions that made decision-making challenging. To navigate this uncertainty, women progressively built their decision through a triple process of making sense: framing RRM as an obligated, empowering and mundane choice. This sense-making process is described as a process of legitimation, through which women decide to undergo RRM and integrate it into their life trajectory, ensuring its acceptability for themselves and their social circles. The discussion provides insights into the legitimation process as a heuristic tool for exploring crucial choices in uncertainty and offers implications for healthcare providers assisting individuals in complex decision-making processes. • RRM decision-making is a challenging process marked by a complex nexus of drivers. • Women gradually build RRM decisions within their family and care providers. • Building a RRM decision requires making sense through a process of legitimation. • RRM decision-making entails framing as an obligated, empowering and mundane choice. • Women need comprehensive support to construct their RRM decision.

SSM - Qualitative Research in HealthVol. 7
University of Applied Sciences and Arts of Southern Switzerland (CH), University of Basel (CH), University Hospital of Bern (CH), University Hospital of Basel (CH), Hospital Base (CL), Ente Ospedaliero Cantonale (CH), Kantonsspital Winterthur (CH), Fribourg Development Agency (CH), University Hospital of Geneva (CH), Hirslanden Clinique des Grangettes (CH), Department of Biomedicine Basel (CH), CABI Switzerland (CH), Università della Svizzera italiana (CH), Université de Strasbourg (FR)
National Science Foundation, Universität Basel, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Krebsliga Schweiz, Centre Hospitalier Universitaire Vaudois, Swiss Cancer Research Foundation
Gender equality
Openalex Percentile: Top 23%
BRCA gene mutations in cancer
0.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.